linagliptin 2.5 MG / metFORMIN HCl 500 MG Oral Tablet

RxCUI
1243027
RxNorm name
linagliptin 2.5 MG / metFORMIN HCl 500 MG Oral Tablet
Display name
linagliptin 2.5 MG / metFORMIN HCl 500 MG Oral Tablet
Full name
linagliptin 2.5 MG / metFORMIN HCl 500 MG Oral Tablet
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:28

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
JentaduetoLINAGLIPTIN AND METFORMIN HYDROCHLORIDEBoehringer Ingelheim Pharmaceuticals, Inc.f6dd9b86-0d18-95d4-2bc7-05591bfdd5972026-08-19Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 1243027
Linagliptin and metformin hydrochlorideLINAGLIPTIN AND METFORMIN HYDROCHLORIDENovadoz Pharmaceuticals LLC5cff87ef-97f9-4e3c-9e06-fd257f3cb3fb2025-11-04Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 1243027

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
f6dd9b86-0d18-95d4-2bc7-05591bfdd597linagliptin 2.5 MG / metFORMIN HCl 500 MG Oral Tablet [PSN] · linagliptin 2.5 MG / metformin hydrochloride 500 MG Oral Tablet [SCD]245These highlights do not include all the information needed to use JENTADUETO safely and effectively. See full prescribing information for JENTADUETO. JENTADUETO ® (linagliptin and metformin hydrochloride tablets), for oral use Initial U.S. Approval: 201220240627
5cff87ef-97f9-4e3c-9e06-fd257f3cb3fblinagliptin 2.5 MG / metFORMIN HCl 500 MG Oral Tablet [PSN] · linagliptin 2.5 MG / metformin hydrochloride 500 MG Oral Tablet [SCD]21These highlights do not include all the information needed to use LINAGLIPTIN and METFORMIN HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for LINAGLIPTIN and METFORMIN HYDROCHLORIDE TABLETS. LINAGLIPTIN and METFORMIN HYDROCHLORIDE tablets, for oral use Initial U.S. Approval: 201220251104